Related Experiment Video

Updated: Dec 4, 2025

Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease
06:45

Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease

Published on: October 4, 2021

3.2K

Brain structural alterations in patients with GCH1 mutations associated DOPA-responsive dystonia

Vladimir S Kostić1, Federica Agosta2,3, Aleksandra Tomic1

  • 1Clinic of Neurology, Faculty of Medicine, University of Belgrade, Belgrade, Serbia.

Journal of Neurology, Neurosurgery, and Psychiatry
|October 22, 2020
PubMed
Summary

No abstract available in PubMed .

Keywords:
MRIdystonia

More Related Videos

Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia
10:41

Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia

Published on: September 12, 2020

7.8K
Gait Analysis of Age-dependent Motor Impairments in Mice with Neurodegeneration
07:46

Gait Analysis of Age-dependent Motor Impairments in Mice with Neurodegeneration

Published on: June 18, 2018

12.4K

Related Experiment Videos

Last Updated: Dec 4, 2025

Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease
06:45

Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease

Published on: October 4, 2021

3.2K
Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia
10:41

Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia

Published on: September 12, 2020

7.8K
Gait Analysis of Age-dependent Motor Impairments in Mice with Neurodegeneration
07:46

Gait Analysis of Age-dependent Motor Impairments in Mice with Neurodegeneration

Published on: June 18, 2018

12.4K

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

1.4K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.4K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

801
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
801
Neural Regulation01:37

Neural Regulation

42.5K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
42.5K

Articles linked to this work by shared authors, journal, and citation graph.

Multimodal assessment of clinical and neural changes following multidisciplinary management in functional motor disorders.

Journal of neural transmission (Vienna, Austria : 1996)·2026

Vascular risk factors' impact on motor performance and sensorimotor network structural integrity in multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026

Association Between Substantia Nigra Hyperechogenicity and Central Macular Thickness in Parkinson's Disease.

Biomedicines·2026

Gray Matter Damage and Long-Term Disability, Cognitive Outcome, and Survival in Patients With Multiple Sclerosis.

Neurology·2026

The economic burden of dementia in Europe: COIN-Eu dementia.

Journal of Alzheimer's disease : JAD·2026

Spatiotemporal deep learning for early detection of isolated REM sleep behavior disorder and Parkinson's disease using functional MRI data.

NPJ Parkinson's disease·2026

Associations of self-reported and objectively measured physical activity and amyotrophic lateral sclerosis risk.

Journal of neurology, neurosurgery, and psychiatry·2026

Cerebrospinal fluid haemoglobin as a monitoring biomarker for secondary brain injury after aneurysmal subarachnoid haemorrhage: prospective international multicentre validation study (HeMoVal).

Journal of neurology, neurosurgery, and psychiatry·2026

HLA-dependent association between EBNA1 antibody levels and disability progression in multiple sclerosis.

Journal of neurology, neurosurgery, and psychiatry·2026

Recombinant factor VIIa for spontaneous intracerebral haemorrhage: a meta-analysis of randomised controlled trials.

Journal of neurology, neurosurgery, and psychiatry·2026

Frailty and accelerated dementia onset in genetic, sociodemographic and neuropathologic subgroups.

Journal of neurology, neurosurgery, and psychiatry·2026

Pet hamster exposure is associated with autoimmune cerebellar ataxia: a hospital-based case-control study.

Journal of neurology, neurosurgery, and psychiatry·2026

The pseudouridine synthase PUSL1 modifies U39 of mitochondrial tRNAs and is linked to human neurological phenotypes.

Nucleic acids research·2026

TEAD inhibitors re-sensitize drug-resistant NF1 MPNST cells to MEK inhibitors.

microPublication biology·2026

Clinical application of PIRCHE scores: reclassifying immunologic risk in patients with medium eplet mismatch.

Frontiers in immunology·2026

Synergistic optimization strategy for high-performance multilayer SPR biosensor.

Optics express·2026

Use of artificial intelligence for medication adherence assessment in patients with type 2 diabetes: an exploratory study in Morocco using ChatGPT and the validated general medication adherence scale.

Osong public health and research perspectives·2026

An N-Salicyloyl Tryptamine Derivative (Compound 18) Improves Spermatogenic Impairment in Obese Mice via Regulating Insulin Resistance and Enhancing Sertoli Cell Glycolysis.

Molecular and cellular endocrinology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us